Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,058

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data

Whittington, Craig J, Kendall, Tim, Fonagy, Peter, Cottrell, David, Cotgrove, Andrew, Boddington, Ellen·2004·The Lancet

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(04)16043-1

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 18

  1. Costello, 1996, The Great Smoky Mountains Study of Youth: goals, design, methods, and the prevalence of DSM-III-R disorders, Arch Gen Psychiatry, 53, 1129, 10.1001/archpsyc.1996.01830120067012 · DOI · Paper page
  2. Costello, 1989, Developments in child psychiatric epidemiology, J Am Acad Child Adolesc Psychiatry, 28, 836, 10.1097/00004583-198911000-00004 · DOI · Paper page
  3. Anderson, 2002, Deaths: leading causes for 2000, Natl Vital Stat Rep, 50, 1
  4. Lewinsohn, 1999, Psychosocial treatments for adolescent depression, Clin Psychol Rev, 19, 329, 10.1016/S0272-7358(98)00055-5 · DOI
  5. Hazell, 2004, Tricyclic drugs for depression in children and adolescents (Cochrane Review)
  6. Garland, 2004, Facing the evidence: antidepressant treatment in children and adolescents, CMAJ, 170, 489
  7. Herxheimer, 2004, Antidepressants and adverse effects in young patients: uncovering the evidence, CMAJ, 170, 487
  8. Kondro, 2004, Drug company experts advised staff to withhold data about SSRI use in children, CMAJ, 170, 783, 10.1503/cmaj.1040213 · DOI
  9. Melander, 2003, Evidence b(i)ased medicine: selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications, BMJ, 326, 1171, 10.1136/bmj.326.7400.1171 · DOI · Paper page
  10. Ramchandani, 2004, Treatment of major depressive disorder in children and adolescents: most selective serotonin reuptake inhibitors are no longer recommended, BMJ, 328, 3, 10.1136/bmj.328.7430.3 · DOI
  11. McPherson, 2004, Synthesising licensing data to assess drug safety, BMJ, 328, 518, 10.1136/bmj.328.7438.518 · DOI
  12. Review Manager (RevMan) [Computer program], 2003
  13. Emslie, 1997, A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression, Arch Gen Psychiatry, 54, 1031, 10.1001/archpsyc.1997.01830230069010 · DOI · Paper page
  14. Emslie, 2002, Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial, J Am Acad Child Adolesc Psychiatry, 41, 1205, 10.1097/00004583-200210000-00010 · DOI · Paper page
  15. Wagner, 2003, Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials, JAMA, 290, 1033, 10.1001/jama.290.8.1033 · DOI · Paper page
  16. Mandoki, 1997, Venlafaxine in the treatment of children and adolescents with major depression, Psychopharmacol Bull, 33, 149
  17. Wagner, 2003, Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder, J Child Adolesc Psychopharmacol, 13, S53, 10.1089/104454603322126340 · DOI
  18. Kapczinski, 2004, Antidepressants for generalized anxiety disorder (Cochrane Review)

Cited by

See all 1,058

Metadata

Authors
Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E.
Venue
The Lancet
Publisher
Elsevier BV
Published
2004-04
Volume
363
Issue
9418
Pages
1341-1345
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2098631889
Cited by
1,058
References
4
FWCI
11.66
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.